To hear about similar clinical trials, please enter your email below
Trial Title:
Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)
NCT ID:
NCT06354049
Condition:
Cancer Pain
Oncology Pain
Conditions: Official terms:
Neoplasms
Cancer Pain
Conditions: Keywords:
Reiki
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Reiki
Description:
Reiki, originating in Japan, is a biofield therapy where a skilled practitioner places
their hands on or above the body of the recipient or themselves to induce relaxation and
promote healing.
Arm group label:
Reiki therapy
Summary:
The purpose of this research is to investigate the delivery of Reiki to integrative
oncology patients and assess its potential for improving cancer-related symptoms in this
population.
Detailed description:
Reiki is a biofield therapy originating in Japan, in which a trained practitioner places
their hands on or above the body of a receiver or themselves to generate a relaxation and
healing response. Systematic reviews and meta-analyses report Reiki to be effective for
improving psychological and physical health symptoms. With respect to adults with cancer,
Reiki has been shown to improve participants' relaxation, pain, fatigue, sleep, anxiety,
stress, and wellbeing/quality of life compared to care as usual. However, one study
showed no improvement in comfort and wellbeing in those receiving Reiki compared to sham
Reiki control, but those receiving Reiki reported improvements above usual care.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age 18 - 89.
- Neoplasm diagnosis (i.e., ICD-10 C00 - D49) confirmed in electronic health record
(EHR)/Caisis
- Receiving care at a UH Connor Whole Health Integrative Oncology Clinic.
- Reporting at least three ESAS symptoms ≥4/10 at baseline screening including fatigue
and ≥2 other symptoms on the 9-item questionnaire.
- Able to speak and understand English.
- Has an email address, and access to a computer with internet and/or a mobile device
with a functioning data plan
Exclusion Criteria:
- Significant cognitive impairment that has not been corrected.
- Significant visual impairment that has not been corrected.
- Unable to provide informed consent.
- Active psychosis.
- Pregnancy.
- Metastatic disease.
- Reiki therapy within 3 months of study enrollment
- Active immunotherapy, chemotherapy, or radiation treatment, or completed within 3
months before study start. Aromatase inhibitors and tamoxifen are exceptions.
Gender:
All
Minimum age:
18 Years
Maximum age:
89 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Address:
City:
Cleveland
Zip:
44106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Santosh Rao, MD
Phone:
858-945-2446
Email:
Santosh.Rao@UHhospitals.org
Investigator:
Last name:
Santosh Rao, MD
Email:
Principal Investigator
Start date:
August 7, 2024
Completion date:
March 31, 2025
Lead sponsor:
Agency:
Case Comprehensive Cancer Center
Agency class:
Other
Source:
Case Comprehensive Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06354049
